
Nona Biosciences Partners with MedUni Vienna for Antibody Research
The Ignaz Semmelweis Institute at the Medical University of Vienna is integrating Nona Biosciences’ H2L2 Harbour Mice platform into its infectious disease research. By utilizing these transgenic mice to generate fully human antibodies, the team aims to accelerate the development of antiviral therapies and improve global pandemic preparedness.






















